- Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy2022 | Third Faculty of Medicine
- DIPG-like MYB-altered diffuse astrocytoma with durable response to intensive chemotherapy2023 | Second Faculty of Medicine
- Radical surgery and intensive chemotherapy are necessary for successful treatment of osteosarcoma2009 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Ex Vivo Expansion of Progenitor Cells after Intensive Chemotherapy in Breast CancerPublication without faculty affiliation
- Whole blood rich in (PBPC) - supportive haemotherapy after intensive chemotherapy in breast cancerPublication without faculty affiliation
- Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial2020 | Third Faculty of Medicine
- Circulation of progenitor cells after intensive chemotherapy followed by combination G-CSF and EPO in breast carcinoma1997 | Faculty of Medicine in Hradec Králové
- Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy2022 | Central Library of Charles University
- Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial2023 | Third Faculty of Medicine
- 6-month follow-up of VIALE-C demonstrates improved and durable efficacy in patients with untreated AML ineligible for intensive chemotherapy2021 | Third Faculty of Medicine
- Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 20022014 | Second Faculty of Medicine
- Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial2007 | Second Faculty of Medicine
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial2012 | Third Faculty of Medicine
- Favorable Outcome of High-Risk Mediastinal Diffuse Large B-Cell Lymphoma (DLBCL) after Dose-Intensive Chemotherapy, Rituximab and Autologous Transplant (ASCT)Publication without faculty affiliation
- Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma2016 | Second Faculty of Medicine
- Ex vivo expansion CD34+/AC133+- selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy1999 | Faculty of Medicine in Hradec Králové
- Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database2017 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine
- Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL12019 | Second Faculty of Medicine
- Fatal course of zygomycosis in a patient treated for diffuse large B-cell non-Hodgkin lymphoma2009 | Second Faculty of Medicine
- Intensive cyclic chemotherapy with unprocessed whole blood support in advanced breast cancer2001 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- The R-megaCHOP-ESHAP-BEAM study for high-risk aggressive B-cell lymphomas: Patients with early PET negativity have excellent lymphoma-free survivalPublication without faculty affiliation
- Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer2000 | Faculty of Medicine in Hradec Králové
- Our experience with the treatment of primary lymphomas of the central nervous system2012 | Faculty of Medicine in Hradec Králové
- The minimal recommended therapeutic strategy in the most frequent haematologic malignancies2005 | First Faculty of Medicine
- Malnutrition, metabolic and nutritional supportive care during bone marrow transplantation2004 | Faculty of Medicine in Hradec Králové
- Acute complications of anticancer treatment, or, Oncological child in PLDD surgery2006 | Second Faculty of Medicine
- Treatment of disseminated zygomycosis in an infant with acute lymphoblastic leukemia with amphotericin B lipid complex2011 | Second Faculty of Medicine
- Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial2018 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene2015 | Second Faculty of Medicine
- Pneumonia caused by Hormographíella verticillata in a child patient with acute leukaemia2012 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport